Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001181431-04-015719
Filing Date
2004-03-16
Accepted
2004-03-16 06:20:41
Documents
2
Period of Report
2004-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 3/A DATED 03/16/2004 rrd36677.html 3/A  
1 FORM 3/A DATED 03/16/2004 rrd36677.xml 3/A 6428
3 POWER OF ATTORNEY rrd28289_32110.htm EX-24.1 3214
  Complete submission text file 0001181431-04-015719.txt   11374
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1124 COLUMBIA STE 130 SEATTLE WA 98103
Business Address
CORDOVA L KATHI (Reporting) CIK: 0001282807 (see all company filings)

Type: 3/A | Act: 34 | File No.: 000-50626 | Film No.: 04671123